RxDoctor Payments Data

Suzanne Euliano

Family · Downers Grove, ILNPI 1679898639

Payments from drug & device makers

$1,580in general payments, 2019–2025

Across 22 payments — averaging $71.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$237
  • Boston Scientific$161
  • W. L. Gore & Associates, Inc.$158
  • Edwards Lifesciences$143
  • Esperion Therapeutics, Inc.$136
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$127
  • plus $618 from 10 others

What the payments were for

  • Food & beverage$1,580100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,580 in reported general payments places this provider in the 80th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois

Medicare billing

Part B allowed, 2024
$45,722
Medicare patients
321
Services billed
473

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban23$21,272
XareltoRivaroxaban21$17,938
BrilintaTicagrelor12$4,892
Prasugrel Hcl15$753
ClopidogrelClopidogrel Bisulfate60$540
Metoprolol Succinate36$504
Atorvastatin Calcium44$354
Nitroglycerin PatchNitroglycerin11$306
Carvedilol39$242
Amlodipine Besylate37$235
Lisinopril26$231
Losartan Potassium27$226
Metoprolol Tartrate43$186
Potassium Chloride20$172
Isosorbide Mononitrate ErIsosorbide Mononitrate12$160

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$28$21,27223 claims
Johnson & JohnsonXarelto$112$17,93821 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,941 family providers in Illinois.

Other family in Downers Grove

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →